Nancy Lee Boman
Chief Regulatory Officer · Vera Therapeutics, Inc.
Individual
- 2026
- Aug 5, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Lee Boman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marshall Fordyce - $7.10M in VERA purchases and sales in the last 12 months
- William D. Turner - $1.45M in VERA purchases and sales in the last 12 months
- Joseph R. Young - $567K in VERA purchases and sales in the last 12 months
- Sean Grant - $208K in VERA purchases and sales in the last 12 months
- David Lee Johnson - $108K in VERA purchases and sales in the last 12 months
- Jason S. Carter - $107K in VERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nancy Lee Boman?
Nancy Lee Boman is a corporate insider, tracked as Chief Regulatory Officer of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy Lee Boman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
